Rossari Biotech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)
Rossari Biotech Ltd · Outcome · 18 Oct 2026, 12:41 am
Rossari Biotech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 6,976 (+19.0% YoY | +0.1% QoQ) ■ EBITDA: 870 (+20.9% YoY | +7.9% QoQ) ■ EBITDA Margin (%): 12.5 (+20 bps YoY | +90 bps QoQ) ■ PAT: 389 (+5.5% YoY | +10.9% QoQ) ■ EPS (INR): 7.02 (+5.6% YoY | +10.9% QoQ)
Original exchange filing (PDF)
More announcements from Rossari Biotech Ltd
- Intimation of Transcript of Q2 & H1 FY27 for the Earnings Conference Call held on October 19, 2026 · 23 Oct 2026
- Audio recording of Earnings Conference Call for Q2 & H1 FY 27. · 20 Oct 2026
- Press Release for Q2 FY27 Results · 19 Oct 2026
- Intimation of Q2 & H1 FY27- Earnings Presentation · 19 Oct 2026
- Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half year ended September 30, 2026. · 18 Oct 2026
- Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 · 18 Oct 2026
- Outcome of Board Meeting held on October 17, 2026. · 18 Oct 2026
- Intimation of Earnings Conference Call for investor and analyst on Monday, October 19, 2026 at 04:00 P.M. (IST). · 19 Oct 2026
